 |
|
|
| |
No Clinically Significant Interaction of MK-3682 With the HIV Medications Dolutegravir, Raltegravir, Rilpivirine, and Tenofovir Disoproxil Fumarate
|
| |
| |
Reported by Jules Levin
The 17th International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy
Washington, DC
June 8-10, 2016
Wei Gao; Leticia Arrington; Xiaoli Shirley Glasgow; Julie Luk; Elizabeth G. Rhee; William L. Marshall; Nancy Kim*; Marian Iwamoto; and Eugene E. Marcantonio *Corresponding author
Merck & Co., Inc., Kenilworth, NJ, USA
|
| |
|
|
|
|
|
